News

Treatment with fidanacogene elaparvovec, a recombinant adeno-associated virus (AAV) vector developed for the treatment of hemophilia B, led to sustained expression of the high-activity factor IX ...
A new study in Human Gene Therapy describes a machine learning (ML) model that can be used as a surrogate for laborious in ...
In a new experimental study, scientists from Juntendo University in collaboration with researchers from the University of Tokyo have developed an adeno-associated virus (AAV) vector-mediated ...
Sangamo Therapeutics shares are surging in Thursday's after-hours session after the company announced a new agreement with pharmaceutical giant Eli Lilly And Co.
Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of its manufacturing-grade IsoTagâ„¢ AAV reagent for the purification of Adeno-associated ...
Two dose levels of a single-administration gene therapy were well-tolerated and led to functional improvements in ambulatory ...